about
Nanotechnology applications in urology: a reviewStrategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and marketEngineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33/ST2 axisImproved efficacy and reduced toxicity of doxorubicin encapsulated in sulfatide-containing nanoliposome in a glioma modelSelection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines.Cancer-cell targeting and photoacoustic therapy using carbon nanotubes as "bomb" agents.Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein.In vitro optimization of liposomal nanocarriers prepared from breast tumor cell specific phage fusion protein.Nano-polypharmacy to treat tumors: coencapsulation of drug combinations using nanoparticle technology.Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicSelective ex-vivo photothermal ablation of human pancreatic cancer with albumin functionalized multiwalled carbon nanotubesAccelerated killing of cancer cells using a multifunctional single-walled carbon nanotube-based system for targeted drug delivery in combination with photothermal therapy.Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticlesIntegrin α3β1 as a breast cancer targetNanoengineering of therapeutics for retinal vascular disease.EILDV-conjugated, etoposide-loaded biodegradable polymeric micelles directing to tumor metastatic cells overexpressing α4β1 integrinReduction of apoptosis by proanthocyanidin-induced autophagy in the human gastric cancer cell line MGC-803.Nanotechnology: A Revolution in Cancer DiagnosisRaman microscopy for noninvasive imaging of pharmaceutical nanocarriers: intracellular distribution of cationic liposomes of different composition.HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy.Recent advances in nanoparticle-based Förster resonance energy transfer for biosensing, molecular imaging and drug release profilingHexanoyl-Chitosan-PEG Copolymer Coated Iron Oxide Nanoparticles for Hydrophobic Drug Delivery.Exploring targeted pulmonary delivery for treatment of lung cancer.Factors affecting the clearance and biodistribution of polymeric nanoparticles.Site-specific, thiol-mediated conjugation of fluorescent probes to cysteine-modified diabodies targeting CD20 or HER2Graphene-based platforms for cancer therapeuticsCellular senescence, ageing and diseaseNanotechnology in urologyAdjuvant approaches to enhance cryosurgery.Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation.Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?Nanotechnology and its relationship to interventional radiology. Part II: Drug Delivery, Thermotherapy, and Vascular Intervention.The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.Nanomaterials: applications in cancer imaging and therapy.Magnetite Nanoparticles for Medical MR Imaging.Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.Preparation of quantum dot/drug nanoparticle formulations for traceable targeted delivery and therapyIntravesical drug delivery for dysfunctional bladder.
P2860
Q27009446-0589AEA6-284B-4E9E-8499-635097D1C129Q27015050-B16DE4E7-0649-454B-9E92-64FD0D55E26AQ28073956-D193ED4A-A193-4535-9E26-F328C4F0D117Q28397819-BCDA9FEF-4BE5-4198-B193-6F52423DE8DAQ28541327-D872C002-2F11-4DD0-9652-757A973264BFQ31163147-D7201B0C-1E0B-4B3F-BA59-D209A90A8CF5Q33416516-C41EF3B6-54FA-4CF3-9F9C-2D192587291BQ33596415-7CBDB9A6-7E95-40E9-AC5C-2E71BBDF5066Q33806255-EBA68E2D-A77F-4DA2-B235-AC18E15B2DE6Q33870663-BAFC744A-87D2-4BF8-8CC9-2079B5B0965CQ33911056-EC0FE6B7-901E-49D2-A388-F44C1AE0DDDBQ33947931-AF39D5B9-4FF0-423D-95F2-78FAD8094286Q34910276-21FA8932-2B22-4D21-BE75-C4BCD99277F9Q35049224-807D0978-837D-47F1-84E3-EDDCBB0AD69BQ35539262-3783E06C-DB0A-4F69-8114-7743628C3B3CQ35645705-8311A11D-0A9F-431C-B4EF-06EFF415B9CCQ35673648-A8E21BBC-2285-4F62-A5AB-70885B37DD66Q35842490-0B66EC9D-2B86-464F-B0A8-D05C38DEA893Q36080018-AC3D44D0-E2BE-4900-9FC8-816432D3C77EQ36119655-4761FDAD-65D4-49CC-ADEB-3EEFDFCB7B3CQ36448817-B995A5B6-D1A3-49FA-AE66-6D3511B5750CQ36538483-B7D50E1A-73AB-4721-AFB1-CF518FDAFDA2Q36584869-44B1EAD2-0ACB-480F-B8AF-C9FD6CA3158DQ36942012-A0615D7A-4EA6-4E35-BECE-33C6CD03186BQ37146591-DE33F851-DA1B-4FEB-8FD7-D8C4FE15CAAEQ37158166-FACF7468-F038-45E7-BABC-7660AB870A57Q37158662-65F00945-2A58-4F6F-88A0-D4FFAEFF88E1Q37398698-6AD28BB5-CA65-4714-BF55-71AD95CF428FQ37465592-3C361C29-FDB5-4325-B779-406CF66AB418Q37565553-54D81712-045F-49BE-B684-5EF76A06F05EQ37714256-6C88AA5C-8E08-4153-914A-54C81162990BQ37763152-CFC2ABD5-45F4-457B-82B5-7F172A81A651Q37772453-80CBC0BF-8818-4082-BBEB-EF6C04DE1608Q37789181-D65CF612-519E-4D94-9E69-FAAF9A6CF48DQ37815479-C6145CE0-C9D9-4954-851E-1377C571DC30Q37857064-F604BD74-883B-4F8F-AA91-D7C4FB6AE9A6Q37990502-67C0F5F0-935E-4611-B8E2-2984F62A0AECQ38028961-DF46BA54-90DB-4EB9-BACF-21ADA993F7B5Q38034961-5EC8F124-C1A4-4B86-95E5-7199E4E35743Q38075592-DA0FA70B-3C41-47A2-AFD1-11DFB715EF1C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New frontiers in nanotechnology for cancer treatment.
@en
New frontiers in nanotechnology for cancer treatment.
@nl
type
label
New frontiers in nanotechnology for cancer treatment.
@en
New frontiers in nanotechnology for cancer treatment.
@nl
prefLabel
New frontiers in nanotechnology for cancer treatment.
@en
New frontiers in nanotechnology for cancer treatment.
@nl
P2093
P1433
P1476
New frontiers in nanotechnology for cancer treatment.
@en
P2093
Aleksandar F Radovic-Moreno
Frank Alexis
Jerome P Richie
June-Wha Rhee
Omid C Farokhzad
Robert Langer
P356
10.1016/J.UROLONC.2007.03.017
P577
2008-01-01T00:00:00Z